The presence of IDRFs can predict the extent of the surgery, and it should be integrated as part of the treatment plan, but it is probably best used in association with other prognosis factors, such as MYCN amplification, NSE level, tumor size, and histological characteristics [20,21,42,44,45,46]. This evidence concerns the gene MYCN and neoplasm.